OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL)

Historical Holders from Q3 2014 to Q3 2025

Symbol
OCUL on Nasdaq
Type / Class
Equity / Common stock ("Common Shares")
Shares outstanding
213M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
188M
Holdings value
$2.2B
% of all portfolios
0.021%
Grand Portfolio weight change
+0.001%
Number of holders
213
Number of buys
119
Number of sells
-75
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +22.5% $372M $142M 31.8M +62.1% FMR LLC 30 Sep 2025
Deep Track Capital, LP 6.18% -34.7% $153M -$27.6M 13.1M -15.3% Deep Track Capital, LP 30 Sep 2025
Venrock Healthcare Capital Partners III, L.P. 7.3% $151M 12.9M Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
SUMMER ROAD LLC 5.7% $132M 12.1M SUMMER ROAD LLC 04 Dec 2025
BlackRock, Inc. 5.8% $119M 10.2M BlackRock, Inc. 30 Sep 2025
Opaleye Management Inc. 2.76% $34.3M 4.34M Opaleye Management Inc. 31 Dec 2024

Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 188M $2.2B +$371M $11.69 213
2025 Q2 156M $1.45B +$187M $9.28 182
2025 Q1 137M $1.01B +$22.1M $7.33 195
2024 Q4 134M $1.14B -$55.5M $8.54 177
2024 Q3 140M $1.22B +$26.6M $8.70 167
2024 Q2 137M $940M +$86.9M $6.84 148
2024 Q1 123M $1.12B +$454M $9.10 145
2023 Q4 73.7M $329M +$151M $4.46 118
2023 Q3 40.4M $127M -$14.5M $3.14 112
2023 Q2 43.5M $224M +$15.4M $5.16 132
2023 Q1 40.3M $212M +$6.22M $5.27 124
2022 Q4 39.6M $111M -$11.9M $2.81 110
2022 Q3 42.8M $178M -$6.25M $4.15 126
2022 Q2 44.3M $178M +$2.78M $4.02 121
2022 Q1 43.5M $215M +$8.62M $4.95 127
2021 Q4 41.5M $289M -$36.3M $6.97 137
2021 Q3 44.5M $445M -$45.7M $10.00 137
2021 Q2 48.3M $685M +$14M $14.18 146
2021 Q1 47.2M $774M -$65.7M $16.41 149
2020 Q4 50.4M $1.04B +$207M $20.70 146
2020 Q3 39.8M $303M +$7.27M $7.61 101
2020 Q2 38.7M $322M +$85.3M $8.33 103
2020 Q1 28.5M $141M +$17.9M $4.95 87
2019 Q4 25.2M $99.5M +$4.79M $3.95 77
2019 Q3 23.3M $70.8M +$1.14M $3.04 73
2019 Q2 22.7M $99.9M +$3.09M $4.40 66
2019 Q1 22.3M $88.6M +$2.35M $3.97 65
2018 Q4 21.5M $85.5M -$3.74M $3.98 66
2018 Q3 21.6M $149M -$1.2M $6.88 72
2018 Q2 22M $149M +$9.8M $6.75 69
2018 Q1 20.4M $133M +$45.6M $6.51 63
2017 Q4 13.5M $60.1M -$11.8M $4.45 67
2017 Q3 15.6M $96.5M -$1.1M $6.18 71
2017 Q2 15.5M $143M -$26.3M $9.27 71
2017 Q1 18.3M $170M +$20.3M $9.28 73
2016 Q4 17.4M $146M -$10.2M $8.37 76
2016 Q3 18.8M $129M -$2.94M $6.87 70
2016 Q2 19.5M $96.4M -$30.4M $4.95 74
2016 Q1 20.9M $201M -$1.63M $9.66 64
2015 Q4 21.1M $197M -$18.1M $9.37 71
2015 Q3 20M $282M +$49.7M $14.06 66
2015 Q2 16.1M $339M +$93.8M $21.03 71
2015 Q1 10.7M $449M +$241M $41.99 56
2014 Q4 5.01M $118M +$9.26M $23.52 36
2014 Q3 4.63M $69.3M +$69.3M $14.97 33